These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10860133)

  • 1. Potentiation of warfarin anticoagulation associated with topical methyl salicylate.
    Joss JD; LeBlond RF
    Ann Pharmacother; 2000 Jun; 34(6):729-33. PubMed ID: 10860133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential dangers from topical preparations containing methyl salicylate.
    Chan TY
    Hum Exp Toxicol; 1996 Sep; 15(9):747-50. PubMed ID: 8880210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan potentiation of warfarin effect.
    Huang SS; Sung SH; Chiang CE
    Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life-threatening retroperitoneal bleeding due to warfarin-drug interactions.
    Chan TY
    Pharmacoepidemiol Drug Saf; 2009 May; 18(5):420-2. PubMed ID: 19283775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard.
    Yip AS; Chow WH; Tai YT; Cheung KL
    Postgrad Med J; 1990 May; 66(775):367-9. PubMed ID: 2371186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of Warfarin Associated with Salsalate Therapy Resulting in Bleeding.
    Rindone JP; Mellen CK
    Curr Drug Saf; 2018; 13(2):141-143. PubMed ID: 29468979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadvertent exaggerated anticoagulation following use of bismuth subsalicylate in an enterally fed patient receiving warfarin therapy.
    Bingham AL; Brown RO; Dickerson RN
    Nutr Clin Pract; 2013 Dec; 28(6):766-9. PubMed ID: 24163322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
    Clark TR; Burns S
    Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients.
    Kurnik D; Lubetsky A; Loebstein R; Almog S; Halkin H
    Ann Pharmacother; 2003 Nov; 37(11):1603-6. PubMed ID: 14565795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin--topical salicylate interactions: case reports.
    Ramanathan M
    Med J Malaysia; 1995 Sep; 50(3):278-9. PubMed ID: 8926909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
    Parker DL; Hoffmann TK; Tucker MA; Gerschutz GP; Malone PM
    Am J Health Syst Pharm; 2010 Jan; 67(1):38-41. PubMed ID: 20044367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction between warfarin and oral miconazole gel].
    Ogard CG; Vestergaard H
    Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.
    Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM
    Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are one or two dangerous? Methyl salicylate exposure in toddlers.
    Davis JE
    J Emerg Med; 2007 Jan; 32(1):63-9. PubMed ID: 17239735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.